Liquidators of biotech startup in talks over stake in drug firm

Liquidators of biotech startup in talks over stake in drug firm
Synthase Biotech's trademarked enzyme Aloxsyn had been shown to improve the ability of cows to conceive. (Image: Unsplash)
Riley Kennedy
Liquidators of a collapsed animal-breeding startup are in talks about its stake in another drug development company.Set up in 2015, Synthase Biotech had developed a plant-based enzyme that stopped fats from going rancid.The Waikato-based company, which leased premises at AgResearch’s Ruakura campus in Hamilton, initially targeted artificial insemination for the global dairy industry and undertook its first capital raise of $800,000 in 2016.However, it collapsed in June last year after failing to find enough commercial contracts for its pr...

More Primary Sector

Seventh global dairy price drop, supply outstripping demand
Primary Sector

Seventh global dairy price drop, supply outstripping demand

The latest auction will put further pressure on Fonterra's payout.

Investors cream $214m from Fonterra Mainland sale
Primary Sector

Investors cream $214m from Fonterra Mainland sale

From “dismal” returns to a windfall and rocketing unit price. But what's next?

How US politics just delivered NZ a beef break
Primary Sector

How US politics just delivered NZ a beef break

There could be additional tariff rollbacks to come as well.

Dileepa Fonseka 17 Nov 2025